source
- Vertex to acquire Crinetics in $10 billion deal, adding rare-disease drug Palsonify to its portfolioVertex Pharmaceuticals announced a $10 billion transaction to purchase Crinetics Pharmaceuticals. The deal will bring Crinetics' recently launched drug Palsonify into Vertex's portfolio. Palsonify…
- FDA grants accelerated approval to Vera Therapeutics' Trutakna for IgA nephropathyThe FDA has granted accelerated approval to Trutakna (formerly known as atacicept) from Vera Therapeutics for adult patients with IgA nephropathy, a chronic kidney disease that can progress to rena…